Utah Medical Products, Inc. (NASDAQ:UTMD – Get Rating) stock price fell below its 200-day moving average during Wednesday’s trading. The stock has a 200-day moving average of $88.72 and is trading as low as $81.54. Shares of Utah Medical Products last traded at $81.54, with volume of 4,379 shares changing hands.

Separately, StockNews.com began covering Utah Medical Products in a research report on Thursday, March 31. They have set a “Strong Buy” rating on the stock.

The company has a market capitalization of $297.21 million, a price-earnings ratio of 19.51 and a beta of 0.24. The company has a fifty-day moving average price of $84.22 and a 200-day moving average price of $88.72.

Utah Medical Products (NASDAQ:UTMD – Get Rating) last reported results on Tuesday, April 26. The medical device supplier reported earnings per share of $0.96 for the quarter. Utah Medical Products had a return on equity of 14.14% and a net margin of 30.34%. The company had revenue of $12.32 million in the quarter.

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, July 6. Shareholders of record on Friday, June 17 received a dividend of $0.29 per share. The ex-dividend date was Thursday, June 16. This represents a dividend of $1.16 on an annualized basis and a yield of 1.42%. Utah Medical Products’ payout ratio is currently 27.75%.

In related news, Director Barbara A. Payne sold 2,000 shares of the company in a trade that took place on Wednesday, May 11. The stock was sold at an average price of $85.20, for a total value of $170,400.00. As a result of the transaction, the administrator now directly owns 5,338 shares of the company, valued at approximately $454,797.60. The sale was disclosed in a document filed with the Securities & Exchange Commission, accessible via this hyperlink. 6.60% of the shares are held by insiders of the company.

Several large investors have recently changed their positions in UTMD. Amalgamated Bank acquired a new stake in Utah Medical Products in Q1 worth $39,000. Acadian Asset Management LLC bought a new position in Utah Medical Products in Q1 worth $40,000. Lazard Asset Management LLC increased its position in Utah Medical Products shares by 21.3% during the first quarter. Lazard Asset Management LLC now owns 837 shares of the medical device supplier worth $75,000 after acquiring 147 additional shares in the last quarter. BNP Paribas Arbitrage SA increased its position in Utah Medical Products shares by 42.6% during the fourth quarter. BNP Paribas Arbitrage SA now owns 1,239 shares of the medical device supplier worth $124,000 after acquiring 370 additional shares in the last quarter. Finally, MetLife Investment Management LLC increased its position in Utah Medical Products shares by 57.0% during the first quarter. MetLife Investment Management LLC now owns 2,030 shares of the medical device supplier worth $182,000 after acquiring 737 additional shares in the last quarter. 71.44% of the shares are currently held by institutional investors.

Utah Medical Products Company Profile (NASDAQ:UTMD)

Utah Medical Products, Inc. develops, manufactures and distributes medical devices for the healthcare industry. The Company offers fetal monitoring accessories, vacuum assisted delivery systems and other labor and delivery tools; Respiratory hoods for newborns DISPOSA-HOOD; and DELTRAN PLUS blood pressure monitoring systems.

Recommended Stories

Receive daily news and reviews for Utah medical products – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Utah Medical Products and related companies with MarketBeat.com’s free daily email newsletter.